A detailed history of Ci Investments Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Ci Investments Inc. holds 1,099 shares of UTHR stock, worth $400,398. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,099
Previous 1,284 14.41%
Holding current value
$400,398
Previous $409,000 3.67%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$311.04 - $363.55 $57,542 - $67,256
-185 Reduced 14.41%
1,099 $394,000
Q2 2024

Aug 12, 2024

BUY
$228.26 - $319.04 $3,195 - $4,466
14 Added 1.1%
1,284 $409,000
Q1 2024

May 13, 2024

BUY
$210.76 - $249.51 $119,079 - $140,973
565 Added 80.14%
1,270 $292,000
Q4 2023

Feb 12, 2024

SELL
$214.88 - $256.94 $28,579 - $34,173
-133 Reduced 15.87%
705 $155,000
Q3 2023

Nov 13, 2023

SELL
$211.82 - $248.24 $23,512 - $27,554
-111 Reduced 11.7%
838 $189,000
Q2 2023

Aug 11, 2023

BUY
$205.19 - $232.99 $113,470 - $128,843
553 Added 139.65%
949 $209,000
Q1 2023

May 12, 2023

BUY
$212.99 - $276.17 $70,073 - $90,859
329 Added 491.04%
396 $89,000
Q4 2022

Feb 10, 2023

BUY
$205.95 - $280.43 $205 - $280
1 Added 1.52%
67 $19,000
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $203 - $244
-1 Reduced 1.49%
66 $14,000
Q2 2022

Aug 12, 2022

SELL
$174.81 - $241.14 $27,445 - $37,858
-157 Reduced 70.09%
67 $16,000
Q1 2022

May 12, 2022

SELL
$166.16 - $213.96 $2,160 - $2,781
-13 Reduced 5.49%
224 $40,000
Q4 2021

Feb 11, 2022

SELL
$184.32 - $216.08 $533,606 - $625,551
-2,895 Reduced 92.43%
237 $51,000
Q3 2021

Nov 12, 2021

BUY
$179.86 - $214.88 $563,321 - $673,004
3,132 New
3,132 $578,000
Q3 2020

Nov 09, 2020

SELL
$99.9 - $121.13 $229,370 - $278,114
-2,296 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$92.74 - $125.82 $212,931 - $288,882
2,296 New
2,296 $278,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Ci Investments Inc. Portfolio

Follow Ci Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.